Professional Documents
Culture Documents
Supplemental Data
Figure S5. Morphologies of iPS Clones Derived from TTFs with the T58A Mutant
(iPS-TTFgfp4-8~12) or Wild-Type c-Myc (iPS-TTFgfp4wt-1~3)
Bars indicate 200µm.
Figure S6. Expression of ES Cell Marker Genes in iPS Clones Derived from TTFs in Figure S5
Figure S7. Pluripotency of iPS Cells Derived from Adult Tail-Tip Fibroblasts In Vitro
The iPS cells established from TTFs (iPS-TTFgfp4-1, 3 and 7) were harvested by trypsinization
and plated on the bacterial culture dishes and incubated for three days in the medium without LIF.
After incubation, aggregated cells were transferred to gelatin-coated tissue culture dishes and
incubated another three days. Cells were then fixed and incubated with anti-βIII tubulin,
anti-α-fetoprotein or anti-α -smooth muscle actin. Signals were visualized with Cy3-conjugated
secondary antibody. Nucleuses were stained with DAPI. Bars indicate 200 µm. Normal mouse
IgG and normal rabbit IgG antibodies were used as negative controls.
Figure S8. Quantification of RNA and Protein Levels of Oct3/4, Sox2, Klf4, c-myc, and Nanog
RNA levels were determine with real-time PCR with primers specific for endogenous transcripts
(open column) or those common for both endogenous and transgenic transcripts (open and
closed column). Protein levels were determined by Western blot and normalized with β-actin.
Shown are relative expression levels compared to those in ES cells. Data of MEF are also shown.
Figure S9. Expression of p53 and p21 in iPS Cells
We performed real time PCR to determine the RNA levels of p21 (Cdkn1a) and p53 (Trp53) in
iPS cells, ES cells, and MEF. Shown are relative expression levels compared to those in ES cells.
Figure S10. Clonal Analyses of iPS Cells
iPS-TTFgfp4-7 cells were plated at a clonal density (2000 cells per 100-mm dish). Seven days
later, colonies were stained with alkaline phosphatase (upper). Colonies were picked and
expanded for in vitro differentiation analysis. RT-PCR showed the each subclone can
differentiate into all three germ layers (lower).
Figure S11. Transfection Efficiency of the PLAT-E Cells and pMX System
We transfected the GFP-expressing retroviral vector and the control vector at ratios of 1:0, 1:3,
1:9, and 1:23 into MEFs, with a constant amount of total DNA. Forty-eight hours later, cells
were photographed under a fluorescence microscope and analyzed by flow cytometry. Bars
indicate 200 µm. The analysis showed that 88, 83, 81, and 73% of transfected cells expressed
GFP, the mean GFP fluorescence being weaker with decreased concentration of the
GFP-expressing vector. This indicates that ~47% (0.834), ~12% (0.8110), and ~0.05% (0.7324) of
cells transfected with the four, 10, or 24 factors expressed all the factors, respectively. In a
100-mm dish, we plated 8 x 105 cells, of which ~4 x 105 cells should express all the four selected
factors when transfected. By contrast, we obtained ~100 iPS colonies after selection with G418
after introduction of the four factors. Thus, a small portion (~0.02%) of transfected cells becomes
ES-like after introduction of the four selected factors.
Figure S12. Effect of Forced Expression of Ecat1 in iPS Cells on the Expression of ES Cell
Marker Genes
iPS cells (iPS-MEF4-7, MEF10-6, TTFgfp4-3 and TTFgfp4-7) were transfected with pMX-IP
(indicated as -) or pMX-ECAT1-IP encoding Ecat1 (indicated as +). Forty-eight hours after
infection, the cells were selected with 2 µg/ml of puromycin for 2 days to eliminate the
non-infected cells. Total RNA was isolated from these cells and analyzed with RT-PCR. The
effect of ECAT1 was variable. In two clones (iPS-MEF4-7, iPS-TTFgfp4-7), forced expression
of ECAT1 slightly enhance the expression of Nanog and Gdf3. However, in other two clones
(iPS- MEF10-6, iPS-TTFgfp4-3), ECAT1 expression decreased the expression of Nanog. In
iPS-MEF10-6, many other genes were also suppressed by the forced expression of ECAT1. Thus,
it is unlikely that ECAT1 has a strong positive effect on the induction of iPS cells.
Table S1. Symbols, Accession Numbers, and Primers for Cloning of 24 Candidate Factors
CAC CAT GGC ATC TCT AAA GAG GTT TCA GAC
1 Ecat1 AB211060
TTA TAA TAT GAT AAA TGA TTC CCA GGC ATC
AAA AAG CAG GCT GGA TGA TGG TGA CCC TCG TGA
2 Dppa5 NM_025274
(Esg1)
AGA AAG CTG GGT CTG CAT CCA GGT CGG AGA CA
AAA AAG CAG GCT CAA TAA TGG AGG AGT CGG AAT TGG
3 Fbxo15 NM_015798
AGA AAG CTG GGT CCA TTT ATT GCC TCC CAA ACC ATTG
AAA AAG CAG GCT CTG ACA TGA GTG TGG GTC TT
4 Nanog AB093574
AGA AAG CTG GGT AAG TCT CAT ATT TCA CCT GG
AAA AAG CAG GCT GGG GAA TGG CTT TGC CTA
5 ERas NM_181548
AGA AAG CTG GGT CAA AGA TCT TCA GGC TAC AG
AAA AAG CAG GCT CAA TGG GTT CCC GGG AGA CAC
6 Dnmt3l NM_019448
AGA AAG CTG GGT CCT GGT TCT AGG AAA GAC TT
AAA AAG CAG GCT AGA AGG GCC AGG ATG TTC GAG GTC
7 Ecat8 AB211061
AGA AAG CTG GGT GTT GGA AAG GGC TGG CAT GTC GT
AAA AAG CAG GCT CGA CCA TGC AGC CTT ATC AAC G
8 Gdf3 NM_008108
AGA AAG CTG GGT ACA CTC CTA GCC TAG TCC CGA GAC
CAC CAT GTC GAG GCG CAA GCA GGC GAA GCC
13 Sall4 NM_175303
TTA GCT GAC AGC AAT CTT ATT TTC CTC CAG
AAA AAG CAG GCT CCA CCT TCC CCA TGG CTG GAC ACC
14 Oct3/4 NM_013633
(Pou5f1)
AGA AAG CTG GGT TGA TCA ACA GCA TCA CTG AGC TTC
AAA AAG CAG GCT TGT ATA ACA TGA TGG AGA CGG
15 Sox2 NM_011443
AGA AAG CTG GGT TTC ACA TGT GCG ACA GGG GCA GT
TTA TTC ATC GTT GGA CTC CGA GTC TAT CAG
GCT TTC TTA CCT AAA GGA CGA TTT ACA GGT C
AAA AAG CAG GCT CCA GGA TGG CTC AGT GGA ACC AG
23 Stat3 NM_213659
AGA AAG CTG GGT CAC ATG GGG GAG GTA GCA CAC
AAA AAG CAG GCT TCA TCC CCA AGA ATT ACA T
24 Grb2 NM_008163
AGA AAG CTG GGT CTT AGA GCG CCT GGA CGT AG
Table S2. List of Transfection Experiments in This Study
Date Cells Transgenes G418-Resistant Colonies Picked up iPS Clones Established
Colonies
7/19/2005 MEF Mock 0
1 x 105 Ecat1 0
Esg1 0
Fbx15 0
Nanog 0
ERas 0
Dnmt3l 0
Ecat8 0
Gdf3 0
Sox15 0
Dppa4 0
Dppa2 0
Fthl17 0
Sall4 0
Oct3/4 0
Sox2 0
Rex1 0
Utf1 0
Tcl1 0
Dppa3 0
Klf4 0
β-catenin S33Y 0
Myc T58A 0
Stat3-C 0
Grb2 ∆SH2 0
24 factors 22 12 5
MEF24-1-4
MEF24-1-5
MEF24-1-9
MEF24-1-17
MEF24-1-18
8/15/2005 MEF Mock 0
1 x 105 24 factors 29 6 4
MEF24-2-1~4
4 factors − Oct3/4 1 1
Oct3/4 + Sox2 0
Oct3/4 + Klf4 0
Oct3/4 + Myc T58A 0
Sox2 + Klf4 0
Sox2 + Myc T58A 0
Klf4 + Myc T58A 0
10 factors 179 12 5
MEF10-1, MEF10-3,
MEF10-6, MEF10-7,
MEF10-10
11/14/2005 TTF GFP 0
8 x 105 4 factors 3 3 3
TTF4-1~3
10 factors 39 12 12
TTF10-1~12
MSC GFP 0
8 x 105 4 factors 3 3 3
MSC4-1~3
10 factors 0
11/20/2005 MEF GFP 0
8 x 105 4 factors (Myc wt) 43 6 4
MEF4wt-1 MEF4wt-3
MEF4wt-4 MEF4wt-6
4 factors (Myc T58A) 35 6 6
MEF4-13~18
4 factors − Myc 0
12/29/2005 TTFgfp Mock 0
8 x 105 4 factors 13 6 6
TTFgfp4-1~6
4 factors (flox) 3 3 1
TTFgfp4-7
10 factors 17 3 1
TTFgfp10-1
MSCgfp Mock 0
8 x 105 4 factors 3 3 1
MSCgfp-1
10 factors 0
4/11/2006 TTFgfp Mock 0
8 x 105 4 factors (Myc wt) 3 3 3
TTFgfp4wt1~3